Medical Clinic
Medical Spa
Indexable treatment evidence

Philadelphia Center for Anti-Aging has source-ready treatment evidence for Semaglutide evidence. Confirm current medication availability, pharmacy model, and pricing before booking.

Philadelphia Center for Anti-Aging

5(11 reviews)Google
Philadelphia, PA
$500+
Semaglutide evidence
Compare with other providers
+1 215-398-4463

Type

Medical Clinic

Location

Philadelphia, Pennsylvania

Starting At

$500+

Rating

5/5 (11 reviews)

About This Provider

Philadelphia Center for Anti-Aging is a medical clinic listed in the GLP1Search directory serving patients in Philadelphia, PA. Public listing data includes source-ready evidence for Semaglutide evidence; confirm current treatment availability directly with the provider.

Visit their website at phillyantiaging.com for the most current information on pricing, medications, and availability.

Google Reviews

5

Based on 11 Google reviews

Google

Rating Distribution (estimated)

11 total reviews

5
70%
4
20%
3
5%
2
3%
1
2%

Business Details

Accessibility

Wheelchair accessible entranceWheelchair accessible parking lot

Payment Methods

Credit cardsDebit cards

What Patients Should Know

Before You Start

Confirm total monthly costs upfront — including membership fees, medication costs, and consultation charges. Ask about insurance coverage.

Medication Options

GLP-1 medications include Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). Ask which options are available and their sourcing.

Clinical Oversight

Verify your assigned clinician's credentials. Ensure regular check-ins and dose adjustments are part of the program.

Our Independence

GLP1Search does not accept referral fees. All provider data is collected independently from public sources.

Get weekly GLP-1 pricing updates

Provider comparisons, new clinic alerts, and research — delivered to your inbox.

No spam. Unsubscribe anytime.

Not sure which provider is right for you?

Every body is different. Compare pricing, medication options, pharmacy standards, and patient experiences across all 18,771 public provider records, with treatment-evidence and directory-only labels kept separate.